Biological Weapons Convention protocol: status and implications : hearing before the Subcommittee on National Security, Veterans Affairs, and International Relations of the Committee on Government Reform, House of Representatives, One Hundred Seventh Congress, first session, June 5, 2001
United States. Congress. House. Committee on Government Reform. Subcommittee on National Security, Veterans Affairs, and International Relations
U.S. Government Printing Office, 2002 - 104 páginas
Comentarios de la gente - Escribir un comentario
No encontramos ningún comentario en los lugares habituales.
Otras ediciones - Ver todas
able activities additional administration arms control asked believe Biological Weapons Convention biotechnology BWC protocol carried Center certainly chairman's text challenge challenge inspections Chemical Colonel committee compliance concern conducted confidence confidential continuing countries declared defense detect discussed disease draft effective efforts experts facilities Geneva global going Government HOC GROUP House important industry inspections inspectors interest issue KADLEC kind legitimate look means measures meet monitoring National Security nature negotiations objectives on-site Organization parties pharmaceutical PhRMA political position possible potential present probably problem production prohibited proposed protect question reasons regime represent require respond REVIEW ROSENBERG routine SHAYS SMITHSON specific statement strengthen Subcommittee technical Thank things threat TIERNEY tion transparency treaty trial trial inspections United verification violations visits WOOLLETT ZELICOFF
Página 84 - Potter is a professor and director of the Center for Nonproliferation Studies at the Monterey Institute of International Studies (MIIS).
Página 38 - Before the Committee on Government Reform Subcommittee on National Security, Veterans Affairs, and International Relations United States House of Representatives November 18, 2002 Good Morning Mr.
Página 10 - Before the House Committee on Government Reform, Subcommittee on National Security, Veterans Affairs and International Relations, May 17, 2001 Mr.
Página 40 - The agencies which enforce tolerances, the Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) , are forced by their limited equipment and resources to rely almost exclusively on multi-residue analytical methods.
Página 38 - President for Biologies and Biotechnology at the Pharmaceutical Research and Manufacturers of America (PhRMA), the trade association for the research-based pharmaceutical and biotechnology companies that are devoted to inventing new life-saving, cost-effective medicines in the United States.
Página 13 - House of Cards: The Pivotal Importance of a Technically Sound BWC Monitoring Protocol (report no.